Study Evaluating the Efficacy and Safety of Topical Diclofenac Spray in Osteoarthritis of the Knee: Trial I

PHASE3CompletedINTERVENTIONAL
Enrollment

650

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions
Osteoarthritis
Interventions
DRUG

TDS-943 (topical diclofenac sodium 4% spray)

DRUG

celecoxib

OTHER

placebo

Trial Locations (43)

19086

Wallingford

24018

Roanoke

27103

Winston-Salem

27612

Raleigh

30308

Atlanta

30329

Atlanta

30342

Atlanta

32174

Ormond Beach

32259

Jacksonville

32720

DeLand

33024

Pembroke Pines

33614

Tampa

33615

Tampa

33781

Pinellas Park

34474

Ocala

34741

Kissimmee

34996

Stuart

35801

Huntsville

36608

Mobile

38018

Cordova

38119

Memphis

43212

Columbus

43551

Perrysburg

45219

Cincinnati

47714

Evansville

60031

Gurnee

60612

Chicago

61550

Morton

61614

Peoria

63031

Florissant

63141

St Louis

70809

Baton Rouge

75231

Dallas

75235

Dallas

78205

San Antonio

85206

Mesa

85710

Tucson

85741

Tucson

90505

Torrance

90660

Pico Rivera

93108

Santa Barbara

95628

Fair Oaks

02920

Cranston

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mika Pharma GmbH

INDUSTRY